CHRISTINA LAUBERNDS: Open Payments
NPI 1295414761 · BLOOMFIELD HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,294 in 135 payments from 16 companies in 2025. Trend: 2023 $271 · 2024 $1,914 · 2025 $3,294
Food & beverage: $3,294
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $594 |
| GENZYME CORPORATION | 9 | $484 |
| Regeneron Healthcare Solutions, Inc. | 12 | $352 |
| Organon LLC | 21 | $308 |
| Arcutis Biotherapeutics, Inc. | 21 | $292 |
| LNHC, Inc | 8 | $286 |
| PFIZER INC. | 19 | $278 |
| ABBVIE INC. | 16 | $234 |
| Incyte Corporation | 3 | $164 |
| Almirall LLC | 3 | $77 |
Products named: DUPIXENT, OTEZLA, Zoryve, ZELSUVMI, SKYRIZI, CIBINQO, Opzelura, VTAMA.
Industry payments across MI — which companies pay providers there.
